Year: 2024
Type: article
Abstract: It is estimated that 50% of lung transplant recipients will develop chronic lung allograft dysfunction (CLAD) to varying degrees and with various phenotypic presentations. After the first year post-transplant, CLAD is the leading cause of death for these patients and may lead to a need for retransplant. A subset of recipients with CLAD will be candidates for retransplant, and although these patients provide a unique challenge for transplant centers, optimal outcomes are achieved when morbidity and mortality are minimized by all available means.
Source: JTCVS Techniques
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,431
OpenAlex ID: W4402532355